blue cross cover glp 1 BCBSM pulling back on GLP-1 coverage Blue Cross Blue Shield plans

Additionally, a review of 1,494 patients found significant improvements in general psychopathology and positive symptoms, particularly in severely ill patients receiving EPA at doses greater than 1 g/day, along with favorable effects on metabolic parameters such as serum triglycerides (247)

A little more than half of patients who respond to treatment with this medication will maintain the response for up to 51 weeks

Specialists understand proper protocols and monitoring requirements

There is no strong evidence suggesting gender-specific risks, but safety data is limited for both men and women

Yet, despite its importance, many of us may not fully understand how long-term supplementation of this powerful compound can impact our health